skinmedicavideo Video: Histogen's collaboration with SkinMedica on growth factor technology and application to SkinMedica's Tissue Nutrient Solution ®

"Learn from Dr. Gail Naughton, CSO and Founder of Histogen Inc., and Dr. Rahul C. Mehta, R&D Vice President of SkinMedica, how growth factors support skin rejuvenation, how Histogen's Growth Factor Technology complements SkinMedica's flagship product Tissue Nutrient Solution® (TNS), and what innovations can be expected in the future." Read more

Upregulation of Extracellular Matrix Genes Corroborates Clinical Efficacy of Human Fibroblast-Derived Growth Factors in Skin Rejuvanation.
Upregulation of Extracellular Matrix Genes Corroborates Clinical Efficacy of Human Fibroblast-Derived Growth Factors in Skin Rejuvanation.
Journal of Drugs in Dermatology Upregulation of Extracellular Matrix Genes Corroborates Clinical Efficacy of Human Fibroblast-Derived Growth Factors in Skin Rejuvanation.

 Read more

allure-dermtube
"Dr. Gail Naughton discusses the science behind HSC and the future of growth factor technology for skin-care in the November 2017 issue of Allure Magazine."

 Read more

© Histogen Inc., CA 92121